Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 1;139(2):273-277.
doi: 10.1213/ANE.0000000000006759. Epub 2024 Mar 6.

Sugammadex-Associated Anaphylaxis: Summary and Proposed Management

Pamela A Chia  1 , Michael W Wolfe
Affiliations
Review

Sugammadex-Associated Anaphylaxis: Summary and Proposed Management

Pamela A Chia et al. Anesth Analg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Burbridge MA. Incidence of anaphylaxis to sugammadex in a single-center cohort of 19,821 patients. Anesth Analg. 2021;132:93–97.
    1. Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth. 2016;35:1–12.
    1. Min KC, Bondiskey P, Schulz V, et al. Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial. Br J Anaesth. 2018;121:749–757.
    1. Orihara M, Takazawa T, Horiuchi T, et al. Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study. Br J Anaesth. 2020;124:154–163.
    1. Miyazaki Y, Sunaga H, Kida K, et al. Incidence of anaphylaxis associated with sugammadex. Anesth Analg. 2018;126:1505–1508.

MeSH terms

Substances